Partnership
Optimize patient stratification to accelerate oncology clinical development
We are working to halve the failure rate of oncology clinical development.
Author
Founder & COO
GlassMedical AI
Basel, Switzerland
We are GlassMedical AI, accelerating clinical trial development timelines in immunotherapy treatment for oncology. I am the founder and COO.
I am Founder and COO of GlassMedical AI. GlassMedical AI is a tech-bio platform delivering multimodal, explainable AI models that enable accelerated, more effective cancer therapy development and approval.
Partnership
Optimize patient stratification to accelerate oncology clinical development
We are working to halve the failure rate of oncology clinical development.